Morinaga Milk Industry Co., Ltd.

Sunstar Inc.

Kanetada Shimizu

Toshitaka Odamaki

Sachiko Takahashi

Noriyuki Iwabuchi

Tomohiro Tanaka

Yohei Sato

Ayako Horigome

Takuma Sakurai

Takumi Sato

Nanami Hashikura

Koji Yamauchi

Tomoko Yaeshima

Tetsuya Kuhara

Shizuki Kondo

Yasumitsu Shimizu

Motomitsu Kitaoka

Mamoru Nishimoto

Yeong Yeh Lee

Yodai Kobayashi

Kazuya Murakami

Yuta Hirano

Tatsuya Itou

Naoki Susaki

Sumiko Yonezawa

Noritoshi Takahashi

Hirotsugu Oda

Hirosuke Sugahara

Kouichi Ogawa

Takako Ishida

Yoshiaki Kiso

Youdai Kobayashi

Kazuhiro Miyaji

Novelbacteria having an opioid peptide decomposition action and a noncollagenous glycoprotein decomposition action are provided. The present invention relates to one or more kinds ofbacteria selected from the group consisting ofMCC1092 (NITE BP-02429),MCC1319 (NITE BP-02431),MCC1868 (NITE BP-02432),MCC1870 (NITE BP-02433), andsubsp.MCC1110 (NITE BP-02430), as well as a composition for decomposing an opioid peptide and composition for decomposing a noncollagenous glycoprotein containing thebacteria as an active ingredient.

Bifidobacterium genus bacterium

genus bacterium

An object of the present invention is to provide an agent for improving a mental health disfunction or a composition for improving a mental health disfunction, and a food or drink composition for improving a mental health disfunction which are effective for improving a mental health disfunction, which are highly safe, and which can be continuously ingested on a daily basis, and this object is achieved by an agent for improving a mental health disfunction or a composition for improving a mental health disfunction, or a food or drink composition for improving a mental health disfunction, each comprising as an active ingredient a bacterium belonging tosubsp.

Composition for alleviating mental health disorder

A composition includes cells ofMCC1849 (NITE BP-01633). The composition is in the form of a pharmaceutical composition, a food, a drink, or a feed. The pharmaceutical composition can be used for treating an inflammatory disease, ulcer, food allergies, bronchial asthma, urticaria, pollinosis, anaphylactic shock or an opportunistic infection.

Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium

A novel agent useful for improving brain function is provided. The active ingredient in this agent is aand/or a-containing cultured material is provided.

Brain function improving agent

A method for prophylaxis or treatment of a disease includes administering an an effective amount of an agent that contains cells ofMCC1849 (NITE BP-01633) to a subject in need of such prophylaxis or treatment. The disease can be one or more of an inflammatory disease, ulcer, food allergies, bronchial asthma, urticaria, pollinosis, anaphylactic shock or an opportunistic infection.

Further enhancement in useful effects of. An oral composition comprising (A)MCC1274 (FERM BP-11175) and (B) at least one cruciferous vegetable selected from the group consisting of broccoli and cabbage.

Oral composition containing bifidobacteria and cruciferous vegetable

TheMCC1849 (NITE BP-01633) strain, which has a high IL-12 production-promoting action, is used as an ingredient of a drug, food or drink, or feed used for promotion of IL-12 production, immunostimulation, antivirus, or the like.

A peptide dimer comprising a peptide consisting of the amino acid sequence of SEQ ID NO: 1 and a peptide consisting of any one of the amino acid sequences of SEQ ID NOS: 2 to 4, wherein the peptide consisting of the amino acid sequence of SEQ ID NO: 1 and the peptide consisting of any one of the amino acid sequences of SEQ ID NOS: 2 to 4 are bound through a disulfide bond between a cysteine residue of each peptide is used as an active ingredient of an agent for promoting proliferation of one or more bacterium selected from the group consisting ofand

Agent for promoting proliferation of bifidobacteria

The present invention relates to a method of treating a liquid composition containing lacto-N-biose, the method including: preparing a liquid composition containing lacto-N-biose having a pH at 25&#xb0; C. of not less than 2.0 and not more than 5.5, and heating the liquid composition at a temperature of 65&#xb0; C. or higher. The present invention can provide a treatment method that enables thermal decomposition of lacto-N-biose to be suppressed when a liquid composition containing lacto-N-biose is heated at a temperature of 65&#xb0; C. or higher, a liquid preparation containing lacto-N-biose that is treated using the treatment method, a dried product produced from such a liquid preparation containing lacto-N-biose, and a method of producing a product containing lacto-N-biose.

Method for treatment of lacto-N-biose-containing solution

An anti-obesity agent or a glucose tolerance-ameliorating agent containing a bacterium belonging to the genusas an active ingredient, wherein the bacterium belonging to the genusexhibits a conversion rate from linoleic acid into conjugated linoleic acid of not more than 10%. The present invention is able to provide an anti-obesity agent and a glucose tolerance-ameliorating agent that are effective for the prevention or treatment of obesity or the amelioration of glucose tolerance and also exhibit superior safety, as well as providing foods or beverages containing these agents. Further, the present invention is also able to provide a bacterium of the genus, and in particular a, that is effective for the prevention or treatment of obesity or the amelioration of glucose tolerance and also exhibits superior safety, as well as providing a pharmaceutical composition containing this bacterium.

Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance

The present invention relates to bacteria of a genushaving bacteriological properties of: (1) fermentability which curdles a 10% (W/W) reconstituted skim milk medium when cultivated at a temperature of 25&#xb0; C. to 37&#xb0; C. for 16 hours; (2)growth-promoting properties which lead to a viable count ofof 5&#xd7;10CFU/g or more, when co-cultivated within the 10% (W/W) reconstituted skim milk medium, until the pH thereof is 4.4 to 4.6; and (3)survivability-improving properties during storage, which lead to a survival rate ofof 30% or more, after co-cultivation within the 10% (W/W) reconstituted skim milk medium until the pH thereof is 4.4 to 4.6, rapid cooling, and two weeks storage at 10&#xb0; C.

Lactic acid bacteria

The present invention provides a method for producing fermented milk, the method employing a lactic acid bacterium capable of improving proliferative properties of, and a fermented milk prepared by the production method. Specifically, the present invention provides a method for producing a fermented milk, including fermenting a fermentation base using bothstrain having cell wall-enveloped proteinase, PrtP, and bacteria belonging to a genus, and a fermented milk prepared by the production method.

Method for producing fermented milk

An acidic lactic acid bacteria beverage having a favorable flavor and an improved survival rate for bifidobacteria. The acidic lactic acid bacteria beverage of the present invention includes bifidobacteria and inulin, wherein the inulin is not fermented by the bifidobacteria. The inulin content is preferably within a range from 1 to 10% by mass, and the pH of the acidic lactic acid bacteria beverage is preferably within a range from 4.1 to 4.8.

Growing community of inventors

Zama, Japan

Kanetada Shimizu